Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04522453
Other study ID # MR/R023697/1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 27, 2020
Est. completion date August 31, 2022

Study information

Verified date September 2022
Source George Washington University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Two strategies will be compared for training and supervising primary care workers delivering mental health services. Both strategies will use the World Health Organization mental health Gap Action Program-Intervention Guide. In the standard strategy, the paper-based version of the mental health Gap Action Program-Intervention Guide will be used. In the novel strategy an electronic version of the mental health Gap Action Program-Intervention Guide that can be used on mobile digital devices will be given to primary care workers. This is a feasibility cluster-randomized controlled trial to establish parameters for conducting a fully-powered cluster-randomized controlled trial comparing the paper versus digital strategy. The primary outcome of the subsequent fully powered trial will be the difference in accurate detection of depression.


Description:

Mental illnesses are common, affecting one in every three people during their lifetimes. Globally, mental illnesses are the leading contributor of years lived with a disability. Despite the prevalence and impact of mental illness, a large difference between true and treated prevalence rates of mental disorders, also known as the mental health treatment gap, exists. It is estimated that more than 80% of people with severe mental illness in low and middle-income countries receive no treatment. Only 16.5% of people with depression living in low- and middle-income countries have access to minimally adequate treatment. The consequences of this treatment gap include symptom persistence and deterioration, social exclusion, and long-term disability of people who could be economically productive and socially included. Globally, there is growing recognition of the importance of mental health as evidenced by its inclusion in the 2030 United Nations Agenda for Sustainable Development and extension of the World Health Organization Comprehensive Mental Health Action Plan to 2030 by the World Health Assembly. Limited numbers of mental health specialists and the concentration of care in hospital settings limits the availability and accessibility of care. Low treatment rates in low- and middle-income countries are related to poor demand and supply-side forces. High levels of stigma associated with mental illness manifest in low rates of help-seeking among those who would benefit from care. The World Health Organization recommends a task-shifting approach to strengthen the generalist workforce and improve access to health care, including mental health care. However, this requires the availability of evidence-based tools and appropriate training, supervision, and support. In recent years there has been an exponential rise in global access to mobile technologies in low- and middle-income countries. In 2012 there were 287 million unique mobile phone subscribers across sub-Saharan Africa covering 32% of the population. Six years later, that number rose to 465 million representing 44% of the population. In Nepal, the number of mobile contracts surpasses the total population (26.49 million). The increased application of mobile technology to healthcare arena, known as mobile health (mobile-health), aims to provide a powerful platform to improve the quality of interventions employing a task-shifting approach and reduce the treatment gap. Mobile health (mobile-health) refers to the use of mobile technology in health interventions and service provision. In a recent World Health Organization survey, 87% of responding countries reported at least one government sponsored mobile-health programme in their country. However, only 14% of countries reported an evaluation of these programmes, raising concerns about insufficient evidence of impact. A systematic review of smartphone use in clinical decision making by healthcare professionals identified seven randomised control trials conducted in high-income settings, which demonstrated improved knowledge, diagnosis, treatment decisions and documentation using mobile-health technology. Studies on mobile-health tools in low- and middle-income countries have had more mixed results. Improved compliance to protocols has been demonstrated with a smart phone tool in India. Conversely, a study in Uganda failed to show improvement in service user outcomes when community-based peer workers used mobile phones to communicate with supervisors. Qualitative data does, however, suggest the intervention facilitated task shifting and improved health worker morale. In 2010, the World Health Organization launched the Mental Health Gap Action Programme Intervention Guide, an evidence-based assessment and management guide for mental, neurological and substance use conditions designed for use by primary and community health staff in low- and middle-income countries. The first edition of the mental health Gap Action Program-Intervention Guide has been implemented in over 100 countries. An updated version was launched in 2016 with new sections and updated evidence-based guidance. The mental health Gap Action Program-Intervention Guide v2.0 consists of eight modules addressing priority conditions (i.e. depression, psychoses, epilepsy, child and adolescent mental and behavioural disorders, dementia, disorders due to substance use, self-harm/suicide and conditions related to extreme stress). The guide provides an overview of common presentations for each condition followed by detailed guidance for assessment, management (including referral to specialist care) and follow-up. The E-mental health Gap Action Program Intervention guide in Low and middle-income countries: proof-of-concept for Impact and Acceptability (Emilia) project seeks to re-address the treatment gap by developing a potentially practicable way for primary health care staff to monitor and treat people with mental illness according to evidence-based guidelines. The project is comprised of three phases: (1) development of an adapted e-mental health Gap Action Program intervention guide, (2) feasibility testing, and (3) knowledge transfer and future work. Objectives Emilia aims to test the feasibility of an electronic version of the mental health Gap Action Program-Intervention Guide v2.0 and trial procedures for the future evaluation of a large-scale trial, which would evaluate differences in depression detection between facilities using e-mental health Gap Action Program vs. paper mental health Gap Action Program. The objectives of this feasibility study, in preparation for a future trial, include the following: 1. To evaluate the feasibility and acceptability of primary care mental health services utilizing the e-mental health Gap Action Program-Intervention Guide for training, supervision, and delivery of care [primary objective]; 2. To determine recruitment and retention rates for primary care workers and patients; 3. To establish the acceptability and feasibility of assessing primary health worker and patient outcomes; 4. To assess ethics and safety procedures using adverse event reporting; 5. To describe depression detection rates in primary health clinics; and 6. To describe depression treatment outcomes in primary health clinics.


Recruitment information / eligibility

Status Completed
Enrollment 3351
Est. completion date August 31, 2022
Est. primary completion date August 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Primary Care Health Workers: Primary healthcare staff will be eligible to participate if they are employed by the primary care clinic or government and have roles and responsibilities that relate to the use of the mental health Gap Action Program (e.g. direct clinical use or supervision). All relevant primary care staff, regardless of individual study participation, will receive training in the mental health Gap Action Program. (electronic or paper version) and have ongoing remote support and supervision. - Patients: Attending primary care for treatment; fluent in Nepali (for Nepal site) or Yoruba (for Nigeria site); Exclusion Criteria: - Primary Care Health Workers: No exclusion criteria. - Patients: Adult attendees will be deemed ineligible for the study if they are unable to understand or complete study assessment (e.g. individuals with severe learning disability or dementia), unable give informed consent, or have a medical emergency requiring immediate intervention.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
paper-based version of mental health Gap Action Program-Intervention Guide
A paper-based guide for diagnosis and management of mental disorders in primary care.
digital version of the mental health Gap Action Program-Intervention Guide
A digital guide and client data entry tool for diagnosis and management of mental disorders in primary care.

Locations

Country Name City State
Nepal Transcultural Psychosocial Organization Nepal Kathmandu
Nigeria University of Ibadan Ibadan Oyo State

Sponsors (7)

Lead Sponsor Collaborator
George Washington University Duke University, King's College London, Medical Research Council, Transcultural Psychosocial Organization Nepal, University of Ibadan, World Health Organization

Countries where clinical trial is conducted

Nepal,  Nigeria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mental Health Gap Action Programme Depression Diagnosis Tool Unnabbreviated name of scale: "Mental Health Gap Action Programme Depression Diagnosis Tool"; Primary care health workers diagnosis of depression documented in clinical records; Unit of measure: % of patients with Mental Health Gap Action Programme Depression Diagnosis compared to number of patients with positive Patient Health Questionnaire depression screen Three months post training
Secondary Mental Health Gap Action Programme Depression Diagnosis Tool Unnabbreviated name of scale: "Mental Health Gap Action Programme Depression Diagnosis Tool"; Primary care health workers diagnosis of depression documented in clinical records; Unit of measure: % of patients with Mental Health Gap Action Programme Depression Diagnosis compared to number of patients with positive Patient Health Questionnaire depression screen One month prior to training
Secondary Patient health questionnaire 9 Unabbreviated scale title "Patient health questionnaire 9"; Self reported symptoms of depression; minimum 0, maximum 27; high score is worse outcome One month prior to training
Secondary Patient health questionnaire 9 Unabbreviated scale title "Patient health questionnaire 9"; Self reported symptoms of depression; minimum 0, maximum 27; high score is worse outcome Three months post training
Secondary Patient health questionnaire 9 Unabbreviated scale title "Patient health questionnaire 9"; Self reported symptoms of depression; minimum 0, maximum 27; high score is worse outcome Six months post training
Secondary World Health Organization Disability Assessment Schedule Unabbreviated name of scale: "World Health Organization Disability Assessment Schedule"; Self reported measure of functional impairment; Minimum score 0, Maximum 60; higher score is worse outcome One month pre training
Secondary World Health Organization Disability Assessment Schedule Unabbreviated name of scale: "World Health Organization Disability Assessment Schedule"; Self reported measure of functional impairment; Minimum score 0, Maximum 60; higher score is worse outcome Three months post training
Secondary World Health Organization Disability Assessment Schedule Unabbreviated name of scale: "World Health Organization Disability Assessment Schedule"; Self reported measure of functional impairment; Minimum score 0, Maximum 60; higher score is worse outcome Six months post training
Secondary Mental health gap action program knowledge assessment Unabbreviated scale title: "Mental health gap action program knowledge assessment"; Multiple choice test of mental disorder diagnosis and management; Minimum score 0%, Maximum 100%, higher score is better outcome One day pre training
Secondary Mental health gap action program knowledge assessment Unabbreviated scale title: "Mental health gap action program knowledge assessment"; Multiple choice test of mental disorder diagnosis and management; Minimum score 0%, Maximum 100%, higher score is better outcome One day post training
Secondary Mental health gap action program knowledge assessment Unabbreviated scale title: "Mental health gap action program knowledge assessment"; Multiple choice test of mental disorder diagnosis and management; Minimum score 0%, Maximum 100%, higher score is better outcome Three months post training
Secondary Mental health gap action program knowledge assessment Unabbreviated scale title: "Mental health gap action program knowledge assessment"; Multiple choice test of mental disorder diagnosis and management; Minimum score 0%, Maximum 100%, higher score is better outcome Eight months post training
Secondary Enhancing Assessment of Common Therapeutic Factors Unabbreviated title: "Enhancing Assessment of Common Therapeutic Factors"; Objective structured clinical examination of common factors and diagnostic practices; Minimum=15, Maximum=60; higher score is better outcome One day pre training
Secondary Enhancing Assessment of Common Therapeutic Factors Unabbreviated title: "Enhancing Assessment of Common Therapeutic Factors"; Objective structured clinical examination of common factors and diagnostic practices; Minimum=15, Maximum=60; higher score is better outcome One day post training
Secondary Enhancing Assessment of Common Therapeutic Factors Unabbreviated title: "Enhancing Assessment of Common Therapeutic Factors"; Objective structured clinical examination of common factors and diagnostic practices; Minimum=15, Maximum=60; higher score is better outcome Three months post training
Secondary Enhancing Assessment of Common Therapeutic Factors Unabbreviated title: "Enhancing Assessment of Common Therapeutic Factors"; Objective structured clinical examination of common factors and diagnostic practices; Minimum=15, Maximum=60; higher score is better outcome Eight months post training
Secondary Social Distance Scale Unabbreviated scale title: "Social Distance Scale"; Self reported measure of stigma against persons with mental illness; Minimum score=12, Maximum Score=72; higher score is worse outcome One day pre training
Secondary Social Distance Scale Unabbreviated scale title: "Social Distance Scale"; Self reported measure of stigma against persons with mental illness; Minimum score=12, Maximum Score=72; higher score is worse outcome One day post training
Secondary Social Distance Scale Unabbreviated scale title: "Social Distance Scale"; Self reported measure of stigma against persons with mental illness; Minimum score=12, Maximum Score=72; higher score is worse outcome Three months post training
Secondary Social Distance Scale Unabbreviated scale title: "Social Distance Scale"; Self reported measure of stigma against persons with mental illness; Minimum score=12, Maximum Score=72; higher score is worse outcome Eight months post training
Secondary Enhancing Assessment of Common Therapeutic Factors - patient version Unabbreviated scale title: "Enhancing Assessment of Common Therapeutic Factors - patient version"; Patient report of primary care workers common factors skills; minimum score=0, maximum score=15; higher score is better outcome One month pre training
Secondary Enhancing Assessment of Common Therapeutic Factors - patient version Unabbreviated scale title: "Enhancing Assessment of Common Therapeutic Factors - patient version"; Patient report of primary care workers common factors skills; minimum score=0, maximum score=15; higher score is better outcome Three months post training
Secondary Enhancing Assessment of Common Therapeutic Factors - patient version Unabbreviated scale title: "Enhancing Assessment of Common Therapeutic Factors - patient version"; Patient report of primary care workers common factors skills; minimum score=0, maximum score=15; higher score is better outcome Six months post training
Secondary Acceptability of Intervention Measure Unabbreviated scale title "Acceptability of Intervention Measure"; Subjective report of acceptability of intervention; A 5-item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Minimum=5, Maximum=25; higher score is better Three months post training
Secondary Acceptability of Intervention Measure Unabbreviated scale title "Acceptability of Intervention Measure"; Subjective report of acceptability of intervention; A 5-item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Minimum=5, Maximum=25; higher score is better Eight months post training
Secondary Acceptability of Intervention Measure - patient version Unabbreviated scale title "Acceptability of Intervention Measure"; Subjective report of acceptability of intervention; A 5-item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Minimum=5, Maximum=25; higher score is better Six months post training
Secondary Feasibility of Intervention Measure Unabbreviated title: " Feasibility of Intervention Measure"; Subjective report of feasibility of intervention; measures the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting. Minimum=5, Maximum=25; higher score is better Three months post training
Secondary Feasibility of Intervention Measure Unabbreviated title: " Feasibility of Intervention Measure"; Subjective report of feasibility of intervention; measures the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting. Minimum=5, Maximum=25; higher score is better Eight months post training
Secondary Intervention Appropriateness Measure Unabbreviated title: " Intervention Appropriateness Measure"; Subjective report of appropriateness of intervention; A 5-item scale that measures the perceived fit, relevance, or compatibility of the innovation or evidence-based practice for a given practice setting, provider, or consumer, and/or perceived fit of the innovation to address a particular issue or problem. Minimum=5, Maximum=25; higher score is better Three months post training
Secondary Intervention Appropriateness Measure Unabbreviated title: " Intervention Appropriateness Measure"; Subjective report of appropriateness of intervention; A 5-item scale that measures the perceived fit, relevance, or compatibility of the innovation or evidence-based practice for a given practice setting, provider, or consumer, and/or perceived fit of the innovation to address a particular issue or problem. Minimum=5, Maximum=25; higher score is better Eight months post training
Secondary Intervention Appropriateness Measure - patient version Unabbreviated title: " Intervention Appropriateness Measure"; Subjective report of appropriateness of intervention; A 5-item scale that measures the perceived fit, relevance, or compatibility of the innovation or evidence-based practice for a given practice setting, provider, or consumer, and/or perceived fit of the innovation to address a particular issue or problem. Minimum=5, Maximum=25; higher score is better Six months post training
Secondary Organizational Readiness for Implementing Change Unabbreviated title: "Organizational Readiness for Implementing Change"; Subjective report of readiness for implementing a new intervention; a 16-item tool to assess Assesses perspectives on intra- and extra-organizational implementation readiness; minimum=16, maximum=90; higher score is better One day pre training
Secondary Normalization Measure Development Unabbreviated title: "Normalization Measure Development"; Subjective report of normalization of measure development; a brief self-report questionnaire that could be helpful in measuring implementation progress. Based on the Normalization Process Theory, this instrument focuses on 4 generative mechanisms involved in implementation processes: coherence, cognitive participation, collective action, and reflexive monitoring. 20 items; minimum=20, maximum=100, higher score is better outcome Eight months post-training
Secondary Perceptions of supervisory support scale Unabbreviated title: "Perceptions of supervisory support scale"; Health workers perception of supervision support; 19 items, minimum score=19, maximum score=95; higher score is better outcome Eight months post-training
Secondary Depression Attitudes Questionnaire Unabbreviated title:"Depression Attitudes Questionnaire"; Health workers report of attitudes toward depression care; Minimum=10; Maximum=40, higher scores=better outcome One day pre training
Secondary Depression Attitudes Questionnaire Unabbreviated title:"Depression Attitudes Questionnaire"; Health workers report of attitudes toward depression care; Minimum=10; Maximum=40, higher scores=better outcome One day post training
Secondary Depression Attitudes Questionnaire Unabbreviated title:"Depression Attitudes Questionnaire"; Health workers report of attitudes toward depression care; Minimum=10; Maximum=40, higher scores=better outcome One month post training
Secondary Depression Attitudes Questionnaire Unabbreviated title:"Depression Attitudes Questionnaire"; Health workers report of attitudes toward depression care; Minimum=10; Maximum=40, higher scores=better outcome Three months post training
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A